Hyundai Cancer Institute :: Bone and Soft Tissue Sarcoma Treatment Program
The multidisciplinary Bone and Soft Tissue Sarcoma Treatment Program at the Hyundai Cancer Institute at CHOC Children’s combines the expertise of pediatric and medical oncologists, orthopedic oncology surgeons, radiation oncologists, pathologists, physical therapists, prosthetic specialists, social workers and child life specialists to provide patients compassionate, family-centered care. Our specialists balance the need for aggressive treatment with the need to provide patients with the highest quality of life both during and after cancer treatment. To accomplish this mission, the team works with patients, their families and the Cancer Institute Tumor Board to make decisions that are the most appropriate for treatment yet keep long-term impact as minimal as possible. Our patients have access to the latest treatments, pediatric or adult clinical trials, as well as innovative Phase I clinical trials. In addition, our patients are able to receive all of their treatments in the Cancer Institute’s state-of-the-art facilities—including surgeries, bone marrow transplants, chemotherapy, and much more.
The Bone and Soft Tissue Sarcoma Program at CHOC Children’s treats all bone and soft tissue sarcomas including but not limited to:
- Ewings sarcoma
Bone and Soft Tissue Sarcoma Patient and Family Resources
We understand that a cancer diagnosis is overwhelming. To make the treatment process less confusing and easier to navigate, the Bone and Soft Tissue Sarcoma Team has provided a list of frequently asked questions and answers about life with cancer.
Children’s cancers are very different than adult cancers and must be treated with specific pediatric cancer protocols. Our experience in exclusively treating children, teens, and young adults makes us the experts in the evaluation and treatment of all forms of common childhood and adolescent cancers. A majority of our protocols come from the Children’s Oncology Group (COG), a national organization funded by the National Cancer Institute (NCI). Our relationship with the COG makes us the only medical center in the region offering Phase 1 COG clinical trials for pediatric cancer patients. Learn about our clinical trials.